Literature DB >> 7148881

A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method.

J R Beck, J P Kassirer, S G Pauker.   

Abstract

The physician developing a treatment plan for a particular patient often needs to know the life expectancy associated with the outcomes of therapeutic choices. Currently available methods for estimating life expectancy are cumbersome and of limited clinical use. We describe a simple approximation of life expectancy (the "DEALE") that is based on the assumption that survival follows a simple declining exponential function. In this approach, the reciprocal of the age-, sex-, and race-adjusted life expectancy is used to estimate the mortality rate of a healthy person. The life expectancy of a person who also has one or more diseases is obtained by adding disease-specific mortalities to the age-, sex-, and race-adjusted mortality rate and taking the reciprocal of that sum. In this paper we show that this approximation estimates life expectancy accurately for the great majority of clinical problems.

Entities:  

Mesh:

Year:  1982        PMID: 7148881     DOI: 10.1016/0002-9343(82)90786-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  72 in total

1.  Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model.

Authors:  Pari V Pandharipande; Curtis Heberle; Emily C Dowling; Chung Yin Kong; Angela Tramontano; Katherine E Perzan; William Brugge; Chin Hur
Journal:  Radiology       Date:  2014-11-12       Impact factor: 11.105

2.  Management of asymptomatic chronic aortic regurgitation with left ventricular dysfunction: a decision analysis.

Authors:  H J Biem; A S Detsky; P W Armstrong
Journal:  J Gen Intern Med       Date:  1990 Sep-Oct       Impact factor: 5.128

Review 3.  Stochastic trees and the StoTree modeling environment: models and software for medical decision analysis.

Authors:  Gordon B Hazen
Journal:  J Med Syst       Date:  2002-10       Impact factor: 4.460

4.  Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Rebecca I Hartman; Mukesh G Harisinghani; Adam S Feldman; Peter R Mueller; G Scott Gazelle
Journal:  Radiology       Date:  2010-09       Impact factor: 11.105

5.  Cost-effectiveness of in-home automated external defibrillators for individuals at increased risk of sudden cardiac death.

Authors:  Peter Cram; Sandeep Vijan; David Katz; A Mark Fendrick
Journal:  J Gen Intern Med       Date:  2005-03       Impact factor: 5.128

6.  The relative net health benefit of liver resection, ablation, and transplantation for early hepatocellular carcinoma.

Authors:  Gaya Spolverato; Alessandro Vitale; Aslam Ejaz; Yuhree Kim; Shishir K Maithel; David P Cosgrove; Timothy M Pawlik
Journal:  World J Surg       Date:  2015-06       Impact factor: 3.352

7.  Cost-effectiveness of screening for coronary artery disease in asymptomatic patients with Type 2 diabetes and additional atherogenic risk factors.

Authors:  Yasuaki Hayashino; Sizuko Nagata-Kobayashi; Takeshi Morimoto; Kenji Maeda; Takuro Shimbo; Tsuguya Fukui
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

8.  Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors.

Authors:  Virginie Nerich; Camille Fleck; Loïc Chaigneau; Nicolas Isambert; Christophe Borg; Elsa Kalbacher; Marine Jary; Pauline Simon; Xavier Pivot; Jean-Yves Blay; Samuel Limat
Journal:  Clin Drug Investig       Date:  2017-01       Impact factor: 2.859

9.  Validation of a decision model for preventive pharmacological strategies in postmenopausal women.

Authors:  Sylvie Perreault; Carey Levinton; Claudine Laurier; Yola Moride; Louis-Georges Ste-Marie; Ralph Crott
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

10.  Radiofrequency ablation versus nephron-sparing surgery for small unilateral renal cell carcinoma: cost-effectiveness analysis.

Authors:  Pari V Pandharipande; Debra A Gervais; Peter R Mueller; Chin Hur; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.